Ans Punt

2.7k total citations
75 papers, 1.9k citations indexed

About

Ans Punt is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Pharmacology. According to data from OpenAlex, Ans Punt has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 23 papers in Health, Toxicology and Mutagenesis and 21 papers in Pharmacology. Recurrent topics in Ans Punt's work include Carcinogens and Genotoxicity Assessment (25 papers), Effects and risks of endocrine disrupting chemicals (21 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Ans Punt is often cited by papers focused on Carcinogens and Genotoxicity Assessment (25 papers), Effects and risks of endocrine disrupting chemicals (21 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Ans Punt collaborates with scholars based in Netherlands, Switzerland and United States. Ans Punt's co-authors include Ivonne M.C.M. Rietjens, Peter J. van Bladeren, Benoı̂t Schilter, Thierry Delatour, Bert Spenkelink, Gabriele Scholz, Marelle G. Boersma, Jochem Louisse, A. Spenkelink and Alicia Paini and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Ans Punt

71 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ans Punt Netherlands 27 521 501 429 390 365 75 1.9k
Jos Bessems Netherlands 23 341 0.7× 216 0.4× 576 1.3× 784 2.0× 220 0.6× 52 2.1k
Faith M. Williams United Kingdom 31 460 0.9× 283 0.6× 550 1.3× 563 1.4× 717 2.0× 87 2.8k
Gregory L. Kedderis United States 21 358 0.7× 440 0.9× 292 0.7× 440 1.1× 157 0.4× 43 1.4k
Angela Mally Germany 36 976 1.9× 831 1.7× 358 0.8× 268 0.7× 1.4k 3.7× 82 3.2k
Yoshimitsu Oda Japan 23 985 1.9× 915 1.8× 547 1.3× 335 0.9× 271 0.7× 63 2.2k
Andreas P. Freidig Netherlands 23 402 0.8× 209 0.4× 340 0.8× 141 0.4× 141 0.4× 47 1.4k
William M. Bracken United States 23 778 1.5× 467 0.9× 475 1.1× 579 1.5× 283 0.8× 42 2.6k
Wolfram Parzefall Austria 27 988 1.9× 770 1.5× 487 1.1× 254 0.7× 408 1.1× 51 2.5k
Marcel Mengelers Netherlands 21 487 0.9× 259 0.5× 461 1.1× 97 0.2× 643 1.8× 70 2.4k
Dennis V. Parke United Kingdom 23 547 1.0× 340 0.7× 308 0.7× 699 1.8× 210 0.6× 110 1.9k

Countries citing papers authored by Ans Punt

Since Specialization
Citations

This map shows the geographic impact of Ans Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans Punt more than expected).

Fields of papers citing papers by Ans Punt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ans Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans Punt. The network helps show where Ans Punt may publish in the future.

Co-authorship network of co-authors of Ans Punt

This figure shows the co-authorship network connecting the top 25 collaborators of Ans Punt. A scholar is included among the top collaborators of Ans Punt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ans Punt. Ans Punt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Punt, Ans, Maria Teresa Baltazar, Beate Nicol, et al.. (2025). Building confidence in PBK model predictions in the absence of human kinetic data: Benzophenone-4 case study. ALTEX. 43(1). 113–126.
2.
Atienzar, Franck, Danilo Basili, Myriam Coulet, et al.. (2025). Countdown to 2027 – maximising use of NAMs in food safety assessment: closing the gap for regulatory assessments in Europe. Regulatory Toxicology and Pharmacology. 162. 105863–105863. 2 indexed citations
3.
Schrenk, Dieter, Jörg Fahrer, Xilin Li, et al.. (2024). Toxins in Botanical Drugs and Plant-derived Food and Feed – from Science to Regulation: A Workshop Review. Planta Medica. 90(3). 219–242. 3 indexed citations
4.
Baltazar, Maria Teresa, Paul L. Carmichael, Matthew Dent, et al.. (2024). Advancing systemic toxicity risk assessment: Evaluation of a NAM-based toolbox approach. Toxicological Sciences. 204(1). 79–95. 6 indexed citations
7.
8.
Punt, Ans. (2020). New approach methodologies (NAMs) for human-relevant biokinetics predictions. ALTEX. 37(4). 607–622. 41 indexed citations
9.
Louisse, Jochem, Martin Alewijn, Ad Peijnenburg, et al.. (2019). Towards harmonization of test methods for in vitro hepatic clearance studies. Toxicology in Vitro. 63. 104722–104722. 20 indexed citations
10.
Punt, Ans & Bernadette C. Ossendorp. (2018). Implementation and verification of PBPK modelling codes of TCDD in rats and humans into Berkeley Madonna. EFSA Supporting Publications. 15(11). 1 indexed citations
12.
Berg, J.H.J. van den, Alicia Paini, A. Spenkelink, et al.. (2014). Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo. Food and Chemical Toxicology. 66. 373–384. 12 indexed citations
13.
Boersma, Marelle G., et al.. (2012). Physiologically Based Biokinetic (PBBK) Modeling of Safrole Bioactivation and Detoxification in Humans as Compared With Rats. Toxicological Sciences. 128(2). 301–316. 28 indexed citations
14.
Paini, Alicia, Ans Punt, Gabriele Scholz, et al.. (2012). In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling. Mutagenesis. 27(6). 653–663. 29 indexed citations
15.
Spenkelink, Bert, et al.. (2012). Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat. Toxicology and Applied Pharmacology. 260(3). 271–284. 38 indexed citations
17.
Rietjens, Ivonne M.C.M., Jochem Louisse, & Ans Punt. (2011). Tutorial on physiologically based kinetic modeling in molecular nutrition and food research. Molecular Nutrition & Food Research. 55(6). 941–956. 57 indexed citations
18.
Spenkelink, Bert, Marelle G. Boersma, Ans Punt, et al.. (2010). Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat. Toxicology in Vitro. 25(1). 267–285. 35 indexed citations
19.
Paini, Alicia, Ans Punt, Jochem Louisse, et al.. (2010). Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. Toxicology and Applied Pharmacology. 245(2). 179–190. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026